Tempus AI Net Change in Investments - Total 2023-2025 | TEM

Tempus AI annual/quarterly net change in investments - total history and growth rate from 2023 to 2025. Net change in investments - total can be defined as the total change in long term and short term investments
  • Tempus AI net change in investments - total for the quarter ending March 31, 2025 was $0.008B, a 64% decline year-over-year.
  • Tempus AI net change in investments - total for the twelve months ending March 31, 2025 was $-0.185B, a 901.49% decline year-over-year.
  • Tempus AI annual net change in investments - total for 2024 was $-0.108B, a 0% decline from 2023.
  • Tempus AI annual net change in investments - total for 2023 was $0B, a 0% decline from 2022.
  • Tempus AI annual net change in investments - total for 2022 was $0B, a 0% decline from .
Tempus AI Annual Net Change in Investments - Total
(Millions of US $)
2024 $-108
2023 $N/A
2022 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.156B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.096B 54.00
Hims & Hers Health (HIMS) United States $13.681B 142.14
Inspire Medical Systems (INSP) United States $4.596B 71.81
IRhythm Technologies (IRTC) United States $4.484B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.069B 11.53
Schrodinger (SDGR) United States $1.747B 0.00
Clover Health Investments (CLOV) United States $1.691B 0.00
Phreesia (PHR) United States $1.537B 0.00
Omnicell (OMCL) United States $1.346B 23.74
Azenta (AZTA) United States $1.233B 57.32
10x Genomics (TXG) United States $1.115B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.517B 154.50
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.435B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.372B 825.00
Health Catalyst (HCAT) United States $0.291B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
EUDA Health Holdings (EUDA) Singapore $0.146B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
American Well (AMWL) United States $0.111B 0.00
CareCloud (CCLD) United States $0.086B 3.27
MDxHealth SA (MDXH) Belgium $0.084B 0.00
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
Outset Medical (OM) United States $0.067B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00